Marvel Biosciences Corp.
Marvel Biosciences Corp.
Share · CA57384M1077 (XTSX)
Overview
No Price
Closing Price XTSX 28.10.2025: 0,21 CAD
28.10.2025 19:45
Current Prices from Marvel Biosciences Corp.
ExchangeTickerCurrencyLast TradePriceDaily Change
XTSX: TSX-V
TSX-V
MRVL.V
CAD
28.10.2025 19:45
0,21 CAD
0,010 CAD
+5,00 %
Share Float & Liquidity
Free Float 67,77 %
Shares Float 35,89 M
Shares Outstanding 52,95 M
Company Profile for Marvel Biosciences Corp. Share
Marvel Biosciences Corp. operates as a pre-clinical stage pharmaceutical development biotechnology company. It engages in the discovery and development of synthetic derivative compounds of known drugs that inhibit the A2a adenosine receptor. The company offers Nourianz (Istradefylline, KW-6002) and MB-204 an adenosine A2A receptor antagonist. It targets neurological diseases, such as Alzheimer's disease, depression and anxiety, and non-neurological conditions of cancer; and non-alcoholic steatohepatitis. Marvel Biosciences Corp. is headquartered in Calgary, Canada.
Get up to date insights from finAgent about Marvel Biosciences Corp.

Company Data

Name Marvel Biosciences Corp.
Company Marvel Biosciences Corp.
Website https://marvelbiotechnology.com
Primary Exchange XTSX TSX-V
ISIN CA57384M1077
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO J. Roderick Matheson
Country Canada
Currency CAD
Employees -
Address 505 8th Avenue S.W., T2P 1G2 Calgary
IPO Date 2021-07-13

Ticker Symbols

Name Symbol
TSX-V MRVL.V
More Shares
Investors who hold Marvel Biosciences Corp. also have the following shares in their portfolio:
EXELON 25/31
EXELON 25/31 Bond
STELLAR AFRICAGOLD
STELLAR AFRICAGOLD Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025